Le Lézard
Classified in: Health
Subject: LAW

Independent Pharmacies Sue Major PBM Over Alleged Illegal Price Discrimination And Reimbursement Violations


PHILADELPHIA, May 15, 2020 /PRNewswire/ -- The newest litigation against a major pharmacy benefit manager (PBM) comes from a likely source: its small business victims. More than 50 independent pharmacies have filed a class action lawsuit against OptumRx, a division of UnitedHealth Group, after the company's failure to comply with state pharmacy claims reimbursement law.

The lawsuit alleges OptumRx acted unlawfully by ignoring state legal requirements, paying local pharmacies substantially less than it paid large chain retail pharmacies like CVS or Walgreens and far below what it paid its own mail order pharmacy for the same prescriptions. The lawsuit further alleges OptumRx often knowingly reimbursed local pharmacies below wholesale cost to stock necessary generic prescription drugs.

PBMs administer the prescription drug portion of health insurance and self-insured plans, acting as a middleman between the insurance plan and the pharmacist. Over the last 20 years these companies have accumulated immense, unregulated power - the three largest PBMs controlling up to 80% of the healthcare market - and have utilized that power to increase prescription drug costs, decrease competition and restrict patient choice.

Plaintiffs involved in the lawsuit allege that:

The pharmacies are represented by Mark Cuker and Neal Jacobs of the Jacobs Law Group, which represents over 400 pharmacies in lawsuits pending in Federal Court in Pennsylvania. For more information about the lawsuit, contact Mark Cuker at (215) 531-8522.

 

SOURCE Pharmacists United for Truth and Transparency


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: